Clinical Trial Update: Levosimendan in High Risk Heart Valve Surgery [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 trial evaluating levosimendan in high-risk heart valve surgery for patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Heart Failure | Phase 4 | Status: COMPLETED